Cancer & the life ahead · November 6, 2026
Cancer progress, measured in lives
Decades of gains are changing what can come after a cancer diagnosis.
John Griffin, MD · The Arising
More people are getting a future after cancer, and the change is large enough to see across generations. The American Association for Cancer Research’s 2026 report puts five-year relative survival for all U.S. cancers combined at 71%, compared with 49% in the mid-1970s.
That is a reason to feel hopeful about the direction of medicine. It represents many advances accumulating over time, with prevention, detection and treatment each contributing to progress.
What the numbers mean
Relative survival compares survival among people diagnosed with cancer with expected survival in a comparable general population. It helps account for deaths from other causes. The report’s newer figure describes people diagnosed in 2016–2022.
Earlier diagnosis and shifts in the types of tumors detected also affect survival statistics. The American Cancer Society’s Cancer Statistics, 2026 explains why these numbers work best beside mortality trends, rather than as a measure of treatment alone.
Here is the other important finding: the AACR report records a 35% decline in the age-adjusted U.S. cancer death rate from 1991 to 2024. Smoking reductions have played a major role, alongside improvements in finding and treating cancers. Age adjustment makes the comparison less dependent on changes in the population’s age.
Progress becomes specific
The ACS analysis describes how drugs targeting the biology of chronic myeloid leukemia transformed its outlook, while newer immunotherapies have improved survival in myeloma. These are examples of medicine learning to recognize a disease more precisely and act on that knowledge.
The gains remain uneven. Pancreatic cancer and glioblastoma still have poor outcomes, and access to effective care matters. A population average cannot tell one person what will happen next.
What the years are for
A future after cancer contains ordinary ambitions. Return to work. Finish a piece of music. Help a child become an adult. Make plans with someone you love and expect to be there.
Those ambitions also give survivorship care its job. We should ask about strength, comfort, thinking, relationships and the ability to participate, alongside the cancer’s response. Additional time becomes more valuable when a person can use it.
The useful question is how to carry progress into the next part of someone’s life: what can be preserved, restored or made possible? A better survival curve is a beginning. The life beyond it is the purpose.
From the full November 5, 2026 Arising research edition, pages 71–73; updated here with the original AACR report and ACS analysis. Statistical definitions: NCI SEER.
Go deeper with The Arising
The care and survivorship magazine · Cancer detection and care · Public Atlas · Arising Health